Literature DB >> 12789190

Superficial gyrate erythema as a cutaneous reaction to alendronate for osteoporosis.

Whitney A High1, Jack B Cohen, Wesley Wetherington, Clay J Cockerell.   

Abstract

Alendronate is a bisphosphonate compound used to treat diseases of pathologic bone resorption. Cutaneous reactions to this medication are rare. We report the case of a superficial gyrate erythema that occurred as a reaction to weekly alendronate therapy used in the treatment of postmenopausal osteoporosis.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12789190     DOI： 10.1067/mjd.2003.245

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  4 in total

1.  Cutaneous side effects of antiosteoporosis treatments.

Authors:  Philippe Musette; Jean-Marc Kaufman; René Rizzoli; Patrice Cacoub; Maria Louisa Brandi; Jean-Yves Reginster
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-02       Impact factor: 5.346

Review 2.  Safety of long-term bisphosphonate therapy for the management of osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

Review 3.  Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity.

Authors:  P Musette; M L Brandi; P Cacoub; J M Kaufman; R Rizzoli; J-Y Reginster
Journal:  Osteoporos Int       Date:  2009-11-17       Impact factor: 5.071

4.  Zoledronic Acid-Induced Interface Dermatitis.

Authors:  Farah Succaria; Mary Collier; Meera Mahalingam
Journal:  Am J Dermatopathol       Date:  2015-12       Impact factor: 1.533
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.